MML Investors Services
PCVX icon

MML Investors Services’s Vaxcyte PCVX Stock Holding History

MML Investors Services’s Portfolio PCVX Stock Details PCVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-2,274
Closed -$260K – 2714
2024
Q3 		$260K Buy
+2,274
New +$205K ﹤0.01% 2274
2023
Q1 		– Sell
-5,211
Closed -$250K – 2205
2022
Q4 		$250K Buy
+5,211
New +$204K ﹤0.01% 1895

Other funds holding PCVX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

MML Investors Services's PCVX Position: Q4 2024 in Review

MML Investors Services sold out of Vaxcyte (PCVX) in Q4 2024, closing a stake of 2,274 shares — an estimated $260K sold.

MML Investors Services first reported a position in PCVX in Q4 2022 and held it in 2 quarters. The position peaked at $260K in Q3 2024. 323 funds tracked by Wall St. Rank hold PCVX as of Q4 2024.

  • MML Investors Services reported no remaining Vaxcyte position as of Q4 2024 after selling out during the quarter.
  • MML Investors Services sold 2,274 Vaxcyte shares in Q4 2024, an estimated $260K.
  • MML Investors Services first reported a position in Vaxcyte in Q4 2022 and held it in 2 quarters.
  • MML Investors Services's Vaxcyte position peaked at $260K in Q3 2024.
  • 323 funds tracked by Wall St. Rank held Vaxcyte as of Q4 2024.

Based on MML Investors Services's 13F filing for Q4 2024, filed 13 Feb 2025.